급성 우심 부전의 집중 치료

Intensive management of acute right heart failure

  • 김기범 (서울대학교 의과대학 소아과학교실) ;
  • 노정일 (서울대학교 의과대학 소아과학교실)
  • Kim, Gi Beom (Department of Pediatrics, Seoul National University College of Medicine) ;
  • Noh, Chung Il (Department of Pediatrics, Seoul National University College of Medicine)
  • 투고 : 2007.09.13
  • 심사 : 2007.10.25
  • 발행 : 2007.11.15

초록

Not a few patients in children and adolescents are suffering from right ventricular (RV) dysfunction resulting from various conditions such as chronic lung disease, left ventricular dysfunction, pulmonary hypertension, or congenital heart defect. The RV is different from the left ventricle in terms of ventricular morphology, myocardial contractile pattern and special vulnerability to the pressure overload. Right ventricular failure (RVF) can be evaluated in terms of decreased RV contractility, RV volume overload, and/or RV pressure overload. The management for RVF starts from clear understanding of the pathophysiology of RVF. In addition to correction of the underlying disease, management of RVF per se is very important. Meticulous control of volume status, inotropic agents, vasopressors, and pulmonary selective vasodilators are the main tools in the management of RVF. The relative importance of each tool depends on the individual clinical status. Medical assist device and surgery can be considered selectively in case of refractory RVF to optimal medical treatment.

키워드

참고문헌

  1. Mahmud M, Champion HC. Right ventricular failure complicating heart failure: pathophysiology, significance, and management strategies. Curr Cardiol Rep 2007;9:200-8 https://doi.org/10.1007/BF02938351
  2. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93:1137-46 https://doi.org/10.1136/hrt.2003.025270
  3. Health Central-General Encyclopaedia-right-sided heart failure http://www.healthcentral.com/ency/408/000154.html Accessed September 2007
  4. Mebazaa A, Karpati P, Renaud E, Algotsson L. Acute right ventricular failure-from pathophysiology to new treatments. Intensive Care Med 2004;30:185-96 https://doi.org/10.1007/s00134-003-2025-3
  5. Rosenzweig EB, Barst RJ. Right-sided heart failure. In: Shaddy RE, Wernovsky G, editors. Pediatric heart failure. Taylor & Francis Group 2005:533-66
  6. Piazza G, Goldhaber SZ. The acutely decompensated right ventricle: pathways for diagnosis and management. Chest 2005;128:1836-52 https://doi.org/10.1378/chest.128.3.1836
  7. Vieillard-Baron A, Prin S, Chergui K, Cherqui K, Dubourq O, Jardin F. Hemodynamic instability in sepsis: bedside assessment by Doppler echocardiography. Am J Respir Crit Care Med 2003;168:1270-6 https://doi.org/10.1164/rccm.200306-816CC
  8. Pfisterer M. Right ventricular involvement in myocardial infarction and cardiogenic shock. Lancet 2003;362:392-4 https://doi.org/10.1016/S0140-6736(03)14028-7
  9. Goldhaber SZ, Elliott CG. Acute pulmonary embolism: Part I. Epidemiology, pathophysiology, and diagnosis. Circulation 2003;108:2726-9 https://doi.org/10.1161/01.CIR.0000097829.89204.0C
  10. Louie EK, Lin SS, Reynertson SI, Brundaqe BH, Levitsky S, Rich S. Pressure and volume loading of the right ventricle have opposite effects on left ventricular ejection fraction. Circulation 1995;92:819-24 https://doi.org/10.1161/01.CIR.92.4.819
  11. King L, Wilkins MR. Natriuretic peptide receptors and the heart. Heart 2002;87:314-5 https://doi.org/10.1136/heart.87.4.314
  12. Nagaya N, Nishikimi T, Okano Y, Uematsu M, Satoh T, Kyotani S et al. Plasma brain natriuretic peptide levels in- crease in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998; 31:202-8 https://doi.org/10.1016/S0735-1097(98)81518-0
  13. Kruger S, Graf J, Merx MW, Koch KC, Kunz D, Hanrath P, et al. Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J 2004;147:60-5 https://doi.org/10.1016/S0002-8703(03)00528-3
  14. Kucher N, Goldhaber SZ. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation 2003;108:2191-4 https://doi.org/10.1161/01.CIR.0000100687.99687.CE
  15. Dabestani A, Mahan G, Gardin JM, Takenaka T, Burn C, Allfie A, et al. Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. Am J Cardiol 1987;59:662-8 https://doi.org/10.1016/0002-9149(87)91189-1
  16. Vieillard-Baron A, Prin S, Chergui K, Dubourq O, Jardin F. Echo-Doppler demonstration of acute cor pulmonale at the bedside in the medical intensive care unit. Am J Respir Crit Care Med 2002;166:1310-9 https://doi.org/10.1164/rccm.200202-146CC
  17. Boxt LM. Radiology of the right ventricle. Radiol Clin North Am 1999;37:379-400 https://doi.org/10.1016/S0033-8389(05)70100-7
  18. Bendjelid K, Romand JA. Fluid responsiveness in mechanically ventilated patients: A review of indices used in intensive care. Intensive Care Med 2003;29:352-60 https://doi.org/10.1007/s00134-002-1615-9
  19. Gold J, Cullinane S, Chen J, Seo S, Oz MC, Oliver JA, et al. Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure. Am J Cardiol 2000;85:506-8 https://doi.org/10.1016/S0002-9149(99)00783-3
  20. Stobierska-Dzierzek B, Awad H, Michler RE. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 2001;38:923-31 https://doi.org/10.1016/S0735-1097(01)01486-3
  21. Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure(the LIDO study): a randomized double-blind trial. Lancet 2002;360:196-202 https://doi.org/10.1016/S0140-6736(02)09455-2
  22. Packer M. Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards. Ann Intern Med 1985; 103:258-70 https://doi.org/10.7326/0003-4819-103-2-258
  23. Bhorade S, Christenson J, O Connor M, Lavoie A, Pohlman A, Hall TB. Response to inhaled nitric oxide in patients with acute right heart syndrome. Am J Respir Crit Care Med 1999;159:571-9 https://doi.org/10.1164/ajrccm.159.2.9804127
  24. Ng J, Finney S, Shulman R, Bellingan GJ, Singer M, Glynne PA. Treatment of pulmonary hypertension in the general adult intensive care unit: a role for oral sildenafil? Br J Anaesth 2005;94:774-7 https://doi.org/10.1093/bja/aei114
  25. Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, Winkler J, Borst MM, et al. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. J Am Coll Cardiol 2000;36:176-82
  26. Ghofrani HA, Wiedemann R, Rose F, Olschewski H, Schermuly RT, Weissmann N, et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 2002;136:515-22 https://doi.org/10.1001/archinte.136.5.515
  27. Galie N, Hinderliter AL, Torbicki A, Fourme T, Simonneau G, Pulido T, et al. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol 2003;41:1380-6 https://doi.org/10.1016/S0735-1097(03)00121-9
  28. Jardin F, Vieillard-Baron A. Right ventricular function and positive pressure ventilation in clinical practice: from hemodynamic subsets to respirator settings. Intensive Care Med 2003;29:1426-34 https://doi.org/10.1007/s00134-003-1873-1
  29. Gatecel C, Mebazaa A, Kong R, Guinard N, Kermarrec M, Mateo J, et al. Inhaled nitric oxide improves hepatic tissue oxygenation in right ventricular failure: value of hepatic venous oxygen saturation monitoring. Anesthesiology 1995; 82:588-90 https://doi.org/10.1097/00000542-199502000-00032
  30. Morgan JA, John R, Lee BJ, Oz MC, Naka Y, et al. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg 2004;77:859-63 https://doi.org/10.1016/j.athoracsur.2003.09.048
  31. McNeil K, Dunning J, Morrell NW. The pulmonary physician in critical care: 13. The pulmonary circulation and right ventricular failure in the lTU. Thorax 2003;58:157-62 https://doi.org/10.1136/thorax.58.2.157